Ann W McMahon1, Gerald Dal Pan1. 1. From the Office of Pediatric Therapeutics (A.W.M.), and the Office of Surveillance and Epidemiology (G.D.P.), Food and Drug Administration, Silver Spring, MD.
Authors: H William Kelly; Alice L Sternberg; Rachel Lescher; Anne L Fuhlbrigge; Paul Williams; Robert S Zeiger; Hengameh H Raissy; Mark L Van Natta; James Tonascia; Robert C Strunk Journal: N Engl J Med Date: 2012-09-03 Impact factor: 91.245
Authors: Kimford J Meador; Gus A Baker; Nancy Browning; Morris J Cohen; Rebecca L Bromley; Jill Clayton-Smith; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring Journal: Lancet Neurol Date: 2013-01-23 Impact factor: 44.182
Authors: James A Feinstein; Jonathan Rodean; Matt Hall; Stephanie K Doupnik; James C Gay; Jessica L Markham; Jessica L Bettenhausen; Julia Simmons; Brigid Garrity; Jay G Berry Journal: Pediatrics Date: 2019-06 Impact factor: 7.124
Authors: Tellen D Bennett; Tiffany J Callahan; James A Feinstein; Debashis Ghosh; Saquib A Lakhani; Michael C Spaeder; Stanley J Szefler; Michael G Kahn Journal: J Pediatr Date: 2019-01-25 Impact factor: 4.406
Authors: Rebecca N Jerome; Meghan Morrison Joly; Nan Kennedy; Jana K Shirey-Rice; Dan M Roden; Gordon R Bernard; Kenneth J Holroyd; Joshua C Denny; Jill M Pulley Journal: Drug Saf Date: 2020-06 Impact factor: 5.606
Authors: Jenny W Sun; Sonia Hernández-Díaz; Sebastien Haneuse; Florence T Bourgeois; Seanna M Vine; Mark Olfson; Brian T Bateman; Krista F Huybrechts Journal: JAMA Psychiatry Date: 2021-01-01 Impact factor: 21.596